Targeting CDK9 for the Treatment of Glioblastoma

SIMPLE SUMMARY: Inhibition of cyclin-dependent kinase 9 (CDK9) can impact multiple survival pathways in cancers and may be a promising therapeutic approach for glioblastoma, which is known to be highly resistant to treatments and thus challenging to treat. This review assesses the mechanisms by whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Alice, Pang, Ying, Butler, Madison, Merchant, Mythili, Kim, Olga, Yu, Guangyang, Su, Yu-Ting, Gilbert, Mark R., Levens, David, Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234280/
https://www.ncbi.nlm.nih.gov/pubmed/34207158
http://dx.doi.org/10.3390/cancers13123039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234280/
https://www.ncbi.nlm.nih.gov/pubmed/34207158
http://dx.doi.org/10.3390/cancers13123039

Ejemplares similares